Insider · CIK 0001610106
Gregory M Sullivan
Files at TNXP (Tonix Pharmaceuticals Holding Corp.). First filing -, latest -.
In brief
Gregory M Sullivan files SEC Form 4 as officer at TNXP (Tonix Pharmaceuticals Holding Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gregory M Sullivan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +39,012 | $0.00 | $0 | 39,012 | Feb 26, 2026 |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp. | AGrant or award Stock Optionderivative | +39,011 | $0.00 | $0 | 39,011 | Feb 26, 2026 |
Questions about Gregory M Sullivan
Answered from the filings on this page, as of the latest one.
Is Gregory M Sullivan buying or selling?
Gregory M Sullivan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gregory M Sullivan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gregory M Sullivan has 0.
Where does Gregory M Sullivan file Form 4?
Gregory M Sullivan has filed Form 4 at TNXP (Tonix Pharmaceuticals Holding Corp.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.